Related Experiment Videos
Chronic cyclosporin-induced nephropathy.
S Takahara1, K Ota, K Takahashi
1Department of Urology, Osaka University School of Medicine, Suita-shi, Japan. takahara@uro.med.osaka-u.ac.jp
Clinical Nephrology
|February 24, 2001
Summary
Cyclosporine nephropathy did not impact long-term kidney transplant outcomes in Japanese patients. However, immunological rejection or glomerulonephritis significantly worsened prognosis, regardless of cyclosporine nephropathy presence.
Area of Science:
- Nephrology
- Transplantation Immunology
Background:
- Long-term prognosis of kidney transplant recipients on cyclosporine maintenance therapy remains debated.
- The specific impact of cyclosporine-induced nephropathy on graft survival requires further clarification.
Purpose of the Study:
- To investigate the prognostic effect of cyclosporine nephropathy in Japanese renal transplant recipients.
- To determine if cyclosporine nephropathy influences long-term graft function and survival.
Main Methods:
- Retrospective analysis of 1,323 Japanese kidney transplant recipients treated with cyclosporine between 1982 and 1991.
- Renal biopsy data available for 461 patients to assess cyclosporine nephropathy and other pathologies.
Main Results:
- Patients with cyclosporine nephropathy combined with rejection or glomerulonephritis had significantly worse outcomes (p < 0.01).
- No significant difference in renal function loss at 9 years was observed between patients with no abnormalities and those with isolated cyclosporine nephropathy.
- Unfavorable long-term prognosis was noted in recipients with rejection or glomerulonephritis, even without cyclosporine nephropathy.
Conclusions:
- Cyclosporine nephropathy alone does not appear to significantly influence the long-term prognosis of kidney transplantation.
- Prognosis is primarily determined by underlying conditions like immunological rejection and glomerulonephritis, irrespective of cyclosporine nephropathy.